179 related articles for article (PubMed ID: 22663298)
1. Identification and validation of inhibitor-responsive kinase substrates using a new paradigm to measure kinase-specific protein phosphorylation index.
Li X; Rao V; Jin J; Guan B; Anderes KL; Bieberich CJ
J Proteome Res; 2012 Jul; 11(7):3637-49. PubMed ID: 22663298
[TBL] [Abstract][Full Text] [Related]
2. Unbiased functional proteomics strategy for protein kinase inhibitor validation and identification of bona fide protein kinase substrates: application to identification of EEF1D as a substrate for CK2.
Gyenis L; Duncan JS; Turowec JP; Bretner M; Litchfield DW
J Proteome Res; 2011 Nov; 10(11):4887-901. PubMed ID: 21936567
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive Analysis of in Vivo Phosphoproteome of Mouse Liver Microsomes.
Kwon OK; Sim J; Kim SJ; Sung E; Kim JY; Jeong TC; Lee S
J Proteome Res; 2015 Dec; 14(12):5215-24. PubMed ID: 26487105
[TBL] [Abstract][Full Text] [Related]
4. Quantifying Kinase-Specific Phosphorylation Stoichiometry Using Stable Isotope Labeling In a Reverse In-Gel Kinase Assay.
Li X; Cox JT; Huang W; Kane M; Tang K; Bieberich CJ
Anal Chem; 2016 Dec; 88(23):11468-11475. PubMed ID: 27808495
[TBL] [Abstract][Full Text] [Related]
5. Comparing the efficacy and selectivity of Ck2 inhibitors. A phosphoproteomics approach.
Borgo C; Cesaro L; Hirota T; Kuwata K; D'Amore C; Ruppert T; Blatnik R; Salvi M; Pinna LA
Eur J Med Chem; 2021 Mar; 214():113217. PubMed ID: 33548633
[TBL] [Abstract][Full Text] [Related]
6. Proteomic identification of p38 MAP kinase substrates using in vitro phosphorylation.
Iida N; Fujita M; Miyazawa K; Kobayashi M; Hattori S
Electrophoresis; 2014 Feb; 35(4):554-62. PubMed ID: 24288278
[TBL] [Abstract][Full Text] [Related]
7. Quantitative analysis of a phosphoproteome readily altered by the protein kinase CK2 inhibitor quinalizarin in HEK-293T cells.
Franchin C; Cesaro L; Salvi M; Millioni R; Iori E; Cifani P; James P; Arrigoni G; Pinna L
Biochim Biophys Acta; 2015 Jun; 1854(6):609-23. PubMed ID: 25278378
[TBL] [Abstract][Full Text] [Related]
8. Large-scale identification of phosphorylation sites for profiling protein kinase selectivity.
Imamura H; Sugiyama N; Wakabayashi M; Ishihama Y
J Proteome Res; 2014 Jul; 13(7):3410-9. PubMed ID: 24869485
[TBL] [Abstract][Full Text] [Related]
9. Systematic investigation of hierarchical phosphorylation by protein kinase CK2.
St-Denis N; Gabriel M; Turowec JP; Gloor GB; Li SS; Gingras AC; Litchfield DW
J Proteomics; 2015 Apr; 118():49-62. PubMed ID: 25449829
[TBL] [Abstract][Full Text] [Related]
10. Oligo-aspartic acid conjugates with benzo[c][2,6]naphthyridine-8-carboxylic acid scaffold as picomolar inhibitors of CK2.
Vahter J; Viht K; Uri A; Enkvist E
Bioorg Med Chem; 2017 Apr; 25(7):2277-2284. PubMed ID: 28274673
[TBL] [Abstract][Full Text] [Related]
11. Enzyme Activities of the Ceramide Synthases CERS2-6 Are Regulated by Phosphorylation in the C-terminal Region.
Sassa T; Hirayama T; Kihara A
J Biol Chem; 2016 Apr; 291(14):7477-87. PubMed ID: 26887952
[TBL] [Abstract][Full Text] [Related]
12. Developmental phosphoproteomics identifies the kinase CK2 as a driver of Hedgehog signaling and a therapeutic target in medulloblastoma.
Purzner T; Purzner J; Buckstaff T; Cozza G; Gholamin S; Rusert JM; Hartl TA; Sanders J; Conley N; Ge X; Langan M; Ramaswamy V; Ellis L; Litzenburger U; Bolin S; Theruvath J; Nitta R; Qi L; Li XN; Li G; Taylor MD; Wechsler-Reya RJ; Pinna LA; Cho YJ; Fuller MT; Elias JE; Scott MP
Sci Signal; 2018 Sep; 11(547):. PubMed ID: 30206138
[TBL] [Abstract][Full Text] [Related]
13. Determination of CK2 specificity and substrates by proteome-derived peptide libraries.
Wang C; Ye M; Bian Y; Liu F; Cheng K; Dong M; Dong J; Zou H
J Proteome Res; 2013 Aug; 12(8):3813-21. PubMed ID: 23808766
[TBL] [Abstract][Full Text] [Related]
14. Identification of Endogenous Kinase Substrates by Proximity Labeling Combined with Kinase Perturbation and Phosphorylation Motifs.
Niinae T; Imami K; Sugiyama N; Ishihama Y
Mol Cell Proteomics; 2021; 20():100119. PubMed ID: 34186244
[TBL] [Abstract][Full Text] [Related]
15. CK2 phosphorylation of SAG at Thr10 regulates SAG stability, but not its E3 ligase activity.
He H; Tan M; Pamarthy D; Wang G; Ahmed K; Sun Y
Mol Cell Biochem; 2007 Jan; 295(1-2):179-88. PubMed ID: 16874460
[TBL] [Abstract][Full Text] [Related]
16. Pre-clinical characterization of CX-4945, a potent and selective small molecule inhibitor of CK2 for the treatment of cancer.
Pierre F; Chua PC; O'Brien SE; Siddiqui-Jain A; Bourbon P; Haddach M; Michaux J; Nagasawa J; Schwaebe MK; Stefan E; Vialettes A; Whitten JP; Chen TK; Darjania L; Stansfield R; Bliesath J; Drygin D; Ho C; Omori M; Proffitt C; Streiner N; Rice WG; Ryckman DM; Anderes K
Mol Cell Biochem; 2011 Oct; 356(1-2):37-43. PubMed ID: 21755459
[TBL] [Abstract][Full Text] [Related]
17. Chemical proteomics and functional proteomics strategies for protein kinase inhibitor validation and protein kinase substrate identification: applications to protein kinase CK2.
Gyenis L; Turowec JP; Bretner M; Litchfield DW
Biochim Biophys Acta; 2013 Jul; 1834(7):1352-8. PubMed ID: 23416530
[TBL] [Abstract][Full Text] [Related]
18. Structural basis of CX-4945 binding to human protein kinase CK2.
Ferguson AD; Sheth PR; Basso AD; Paliwal S; Gray K; Fischmann TO; Le HV
FEBS Lett; 2011 Jan; 585(1):104-10. PubMed ID: 21093442
[TBL] [Abstract][Full Text] [Related]
19. Identification and characterization of a novel testis-specific gene CKT2, which encodes a substrate for protein kinase CK2.
Bai X; Silvius D; Chan ED; Escalier D; Xu SX
Nucleic Acids Res; 2009 May; 37(8):2699-711. PubMed ID: 19273531
[TBL] [Abstract][Full Text] [Related]
20. Functional proteomics strategy for validation of protein kinase inhibitors reveals new targets for a TBB-derived inhibitor of protein kinase CK2.
Gyenis L; Kuś A; Bretner M; Litchfield DW
J Proteomics; 2013 Apr; 81():70-9. PubMed ID: 23017496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
